By
Drug Target Review2025-08-21T01:30:03
Researchers at UC San Diego have discovered a graphene-based technology that accelerates the maturation of human brain organoids, offering a safer, non-invasive way to model diseases like Alzheimer’s.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-19T08:26:00Z
2026-06-17T12:40:00Z
2023-11-20T13:43:43
Sponsored by Merck
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-09-27T13:56:39
Sponsored by Euretos
2023-05-10T11:18:16
Sponsored by Revvity
2023-04-04T15:03:09
Sponsored by Agilent
Site powered by Webvision Cloud